scholarly journals Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors

2014 ◽  
Vol 5 (9) ◽  
pp. 2004-2019 ◽  
Author(s):  
Trevor A. Mori
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Fatty Acids ◽  
Docosahexaenoic Acid ◽  
Cardiometabolic Risk ◽  
Epidemiological Studies ◽  
Fish Oils ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Disease Epidemiology

Clinical and epidemiological studies provide support that the polyunsaturated omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid from fish and fish oils are cardioprotective, particularly in the setting of secondary prevention.

scholarly journals Effects of Omega-3 Polyunsaturated Fatty Acids and Their Metabolites on Haemostasis—Current Perspectives in Cardiovascular Disease

2021 ◽  
Vol 22 (5) ◽  
pp. 2394
Author(s):  
Jacek Golanski ◽  
Patrycja Szymanska ◽  
Marcin Rozalski
Keyword(s):  
Cardiovascular Disease ◽  
Fatty Acids ◽  
Blood Platelets ◽  
Epidemiological Studies ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Beneficial Effects ◽  
Omega 6 ◽  
Supporting Tool ◽  
Higher Doses

The beneficial effects of long-chain polyunsaturated omega-3 fatty acids (omega-3 PUFAs) in cardioprotection are widely known and generally accepted. In this literature review, we have focused on the known and postulated mechanisms of action of omega-3 PUFAs and their metabolites on various components of the haemostatic system, in particular on blood platelets and endothelium. We have also made an attempt to provide a comprehensive review of epidemiological studies with particular regard to clinical trials. Notably, the results of these studies are contradictory, and some of them failed to report the beneficial effects of taking or supplementing omega-3 PUFAs in the diet. A potential explanation, in our opinion, could be the need to use higher doses of omega-3 PUFAs and a proper ratio of omega-3 and omega-6 PUFAs. An additional problem which is difficult to solve is the use of a proper neutral placebo for interventional studies. Despite some controversies regarding the beneficial effects of supplementation of omega-3 PUFAs in cardiovascular disease, our review suggests that a promising aspect of future studies and applications is to focus on the anti-thrombotic properties of these compounds. An argument supporting this assumption is the recent use of omega-3 PUFAs as a supporting tool for the treatment of COVID-19 complications.

scholarly journals Omega-3 fatty acids, polymorphisms and lipid related cardiovascular disease risk factors in the Inuit population

2013 ◽  
Vol 10 (1) ◽  
pp. 26 ◽  
Author(s):  
Iwona Rudkowska ◽  
Catherine Ouellette ◽  
Eric Dewailly ◽  
Robert A Hegele ◽  
Véronique Boiteau ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Fatty Acids ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Cardiovascular Disease Risk Factors ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Inuit Population

scholarly journals Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?

2011 ◽  
Vol 33 (4) ◽  
pp. 436-443 ◽  
Author(s):  
D. Kromhout ◽  
S. Yasuda ◽  
J. M. Geleijnse ◽  
H. Shimokawa
Keyword(s):  
Cardiovascular Disease ◽  
Fatty Acids ◽  
Fish Oil ◽  
Omega 3 Fatty Acids ◽  
Omega 3
Sign in / Sign up

Export Citation Format

Share Document